Patent US4778798A successfully refreshed from Google Patents.
US4778798A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Pharmaceutical compositions having vasodilating and antianoxic activities
Assignee: Seuref AG
•
Filing: 1986-07-31
•
Granted: 1988-10-18
•
Expires: 2006-07-31
Abstract
Abstract Pharmaceutical compositions having vasodilating and antianoxic activities containing an ubiquinone or Coenzyme Q 10 and a vasodilating compound selected from the groups of ergotamine, Rauwolfia, vincamine alkaloids, calcium antagonists, β-blockers, papaverine, Ginkgo biloba, xanthine derivatives, ACE inhibitors, cyclospasmol.
Inventors
- 👤 Pierre-Noel Brasey
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 02:13
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/47; A61K31/475; A61K31/12; A61K31/48; A61K31/485; A61P; A61P3/00; A61P3/12; A61P3/14; A61P9/00; A61P9/08
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
71 words
A method of treating pathological conditions related to vascularization disorders at the cerebral and peripheral level, of both primary and seconary origin, due to atherosclerosis, hypertension, senescence or vasal spasms, which consists of administering to a living subject in need of treatment a composition containing an effective amount of Coenzyme Q 10 and nifedipine, said Coenzyme Q 10 and said nifedipine being in the ratio of ranging from 1:100 to 100:1.
Claim 2
Independent Claim
71 words
A method of treating pathological conditions related to vascularization disorders at the cerebral and peripheral level, of both primary and seconary origin, due to atherosclerosis, hypertension, senescence or vasal spasms, which consists of administering to a living subject in need of treatment a composition containing an effective amount of Coenzyme Q 10 and nifedipine, said Coenzyme Q 10 and said nifedipine being in the ratio of ranging from 1:100 to 100:1.
Claim 3
Dependent Claim
47 words
A pharmaceutical composition having antianoxic and vasodilating activities, containing ubiquinone Q 10 coenzyme and one vasodilating compound which is a calcium antagonist wherein the vasodilating compound is nicardipine, nifedipine, nimodipine, said coenzyme Q 10 and said vasodilating compound being in a ratio ranging from 1:100 to 100:1.
Claim 4
Dependent Claim
47 words
A pharmaceutical composition having antianoxic and vasodilating activities, containing ubiquinone Q 10 coenzyme and one vasodilating compound which is a calcium antagonist wherein the vasodilating compound is nicardipine, nifedipine, nimodipine, said coenzyme Q 10 and said vasodilating compound being in a ratio ranging from 1:100 to 100:1.
Claim 5
Dependent Claim
34 words
The pharmaceutical composition according to claim 2 in form of a capsule, a sugar-coated pill, a tablet, a granulate, a syrup, an ampoule and a vial for injectable solutions, for oral or parenteral administration.
References Cited (Backward Citations)
US4599232A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-10-18 | 1992-04-18 | 1992-10-18 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-10-18 | 1996-04-18 | 1996-10-18 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-10-18 | 2000-04-18 | 2000-10-18 | $7700.00 | Window Closed / Lapsed |